Nippon India Pharma Fund
Direct · Growth ₹575.28
23 Apr 2026
NAV
17.0%
3Y CAGR
16.7%
5Y CAGR
16.3%
10Y CAGR
17.2%
Weighted CAGR
?
Weighted Mean CAGR
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
6.56
Sharpe
-24.0%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.69 L | 21.0% | -27.3% | 94.0% |
| 3 Years | ₹36.00 L | ₹45.35 L | 17.0% | -7.0% | 44.9% |
| 5 Years | ₹60.00 L | ₹93.25 L | 17.0% | -2.2% | 30.1% |
| 10 Years | ₹1.20 Cr | ₹3.13 Cr | 17.9% | 12.9% | 21.5% |
Fund SIP vs NIFTY 50
| Duration | Fund XIRR | Benchmark CAGR | Difference |
|---|---|---|---|
| 1 Year | 21.0% | 0.9% | +20.1% |
| 3 Years | 17.0% | 11.2% | +5.8% |
| 5 Years | 17.0% | 11.1% | +5.9% |
| 10 Years | 17.9% | 11.9% | +5.9% |